NCAM1 and type 2 diabetes mellitus: With the present study, we therefore address this issue at a single-cell level by sorting individual CD56+ muscle progenitor cells from people with T2DM and healthy control subjects, and analyzing miRNAs previously reported to be borderline significantly expressed between the two groups (Henriksen et al., 2017).